The University of Chicago Header Logo

Connection

Michael H. Davidson to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Michael H. Davidson has written about Lung Neoplasms.
Michael H. Davidson
Connection Strength
0.057
Lung Neoplasms
  1. A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients. Cancer Chemother Pharmacol. 2016 Feb; 77(2):375-83.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.